bempedoic acid vs cholestyramine

According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.

Side-by-side comparison of bempedoic acid and cholestyramine. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

minor Known Drug Interaction

Cholestyramine Clinical Impact: Concomitant use of NEXLIZET and cholestyramine decreases ezetimibe concentration. Intervention: Administer NEXLIZET either at least 2 hours before or at least 4 hours after bile acid sequestrants [see Dosage and Administration (2.2) ] .

Drug Class
bempedoic acid ACL Inhibitor
cholestyramine Bile Acid Sequestrant
Type
bempedoic acid Prescription
cholestyramine Prescription
Summary
bempedoic acid

No summary available.

cholestyramine

Cholestyramine is a medicine that helps lower high cholesterol levels in your blood. It works by preventing your body from absorbing cholesterol in the intestines.

What It Treats
bempedoic acid

Information not available.

cholestyramine

This medicine is used with a diet to lower high cholesterol, especially LDL cholesterol (the "bad" cholesterol). It may also help if you have high triglycerides, but it's not the best choice if high triglycerides are your main problem. Lowering cholesterol helps reduce your risk of heart disease.

How It Works
bempedoic acid

Information not available.

cholestyramine

Cholestyramine is a resin that binds to bile acids in your intestines. Bile acids help digest fats, including cholesterol. By binding to bile acids, cholestyramine prevents them from being reabsorbed, so your body uses cholesterol to make more bile acids, which lowers cholesterol levels in your blood.

Common Side Effects
bempedoic acid
  • Upper respiratory tract infection
  • Muscle spasms
  • High uric acid levels in the blood
  • Back pain
  • Stomach pain or discomfort
cholestyramine
  • Constipation
FAERS Reports
bempedoic acid
  • Myalgia 335
  • Arthralgia 214
  • Muscle Spasms 153
  • Pain In Extremity 135
  • Nausea 130
cholestyramine
  • Diarrhoea 1,631
  • Fatigue 877
  • Nausea 783
  • Arthralgia 621
  • Headache 543
Serious Warnings
bempedoic acid

No specific warnings noted.

cholestyramine

Since cholestyramine can affect how your body absorbs other medicines, take other drugs at least 1 hour before or 4 to 6 hours after taking cholestyramine.

Pregnancy
bempedoic acid

No pregnancy information available.

cholestyramine

Tell your doctor if you are pregnant or plan to become pregnant. Cholestyramine may affect how you absorb vitamins, so your doctor may recommend supplements. Talk to your doctor about the risks and benefits of taking this medicine while breastfeeding.

Also Compare, Nearby Drugs

Compare cholestyramine with

How to Read This bempedoic acid vs cholestyramine Comparison

bempedoic acid is classified in the ACL Inhibitor drug class, while cholestyramine sits within the Bile Acid Sequestrant class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, bempedoic acid has 967 submissions while cholestyramine has 4,455. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to cholestyramine can lower the amount of the other medicine that your body is able to absorb.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for bempedoic acid or cholestyramine.

Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.